Literature DB >> 21217752

Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Ekkehart Lausch1, Andreas Janecke, Matthias Bros, Stefanie Trojandt, Yasemin Alanay, Corinne De Laet, Christian A Hübner, Peter Meinecke, Gen Nishimura, Mari Matsuo, Yoshiko Hirano, Sylvie Tenoutasse, Andrea Kiss, Rafael Fabiano Machado Rosa, Sharon L Unger, Raffaele Renella, Luisa Bonafé, Jürgen Spranger, Sheila Unger, Bernhard Zabel, Andrea Superti-Furga.   

Abstract

Vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases are the hallmarks of the genetic disorder spondyloenchondrodysplasia. We mapped a locus in five consanguineous families to chromosome 19p13 and identified mutations in ACP5, which encodes tartrate-resistant phosphatase (TRAP), in 14 affected individuals and showed that these mutations abolish enzyme function in the serum and cells of affected individuals. Phosphorylated osteopontin, a protein involved in bone reabsorption and in immune regulation, accumulates in serum, urine and cells cultured from TRAP-deficient individuals. Case-derived dendritic cells exhibit an altered cytokine profile and are more potent than matched control cells in stimulating allogeneic T cell proliferation in mixed lymphocyte reactions. These findings shed new light on the role of osteopontin and its regulation by TRAP in the pathogenesis of common autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217752     DOI: 10.1038/ng.749

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  50 in total

1.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Osteopontin-induced survival of T cells.

Authors:  Ingunn M Stromnes; Joan M Goverman
Journal:  Nat Immunol       Date:  2007-01       Impact factor: 25.606

3.  Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions.

Authors:  M Frydman; J Bar-Ziv; R Preminger-Shapiro; A Brezner; N Brand; T Ben-Ami; R S Lachman; H E Gruber; D L Rimoin
Journal:  Am J Med Genet       Date:  1990-07

4.  Spondyloenchondrodysplasia.

Authors:  H Menger; K Kruse; J Spranger
Journal:  J Med Genet       Date:  1989-02       Impact factor: 6.318

5.  Improved method for measuring tartrate-resistant acid phosphatase activity in serum.

Authors:  M Nakanishi; K Yoh; K Uchida; S Maruo; A Matsuoka
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

6.  Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent.

Authors:  Helena Kaija; Sari L Alatalo; Jussi M Halleen; Ylva Lindqvist; Gunter Schneider; H Kalervo Väänänen; Pirkko Vihko
Journal:  Biochem Biophys Res Commun       Date:  2002-03-22       Impact factor: 3.575

7.  Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro.

Authors:  B Ek-Rylander; M Flores; M Wendel; D Heinegård; G Andersson
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

Review 8.  Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy.

Authors:  Alison R Hayman
Journal:  Autoimmunity       Date:  2008-04       Impact factor: 2.815

Review 9.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

10.  Osteopontin prevents monocyte recirculation and apoptosis.

Authors:  Tricia H Burdo; Malcolm R Wood; Howard S Fox
Journal:  J Leukoc Biol       Date:  2007-03-16       Impact factor: 4.962

View more
  59 in total

Review 1.  [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].

Authors:  C Günther; F Schmidt; N König; M A Lee-Kirsch
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 2.  Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.

Authors:  Alexander A Navarini; Takashi K Satoh; Lars E French
Journal:  Semin Immunopathol       Date:  2015-11-30       Impact factor: 9.623

3.  Against all odds: blended phenotypes of three single-gene defects.

Authors:  Yong Li; Anika Salfelder; Karl Otfried Schwab; Sarah Catharina Grünert; Tanja Velten; Dieter Lütjohann; Pablo Villavicencio-Lorini; Uta Matysiak-Scholze; Bernhard Zabel; Anna Köttgen; Ekkehart Lausch
Journal:  Eur J Hum Genet       Date:  2016-01-27       Impact factor: 4.246

Review 4.  Genetically defined autoinflammatory diseases.

Authors:  A A de Jesus; R Goldbach-Mansky
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

Review 5.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 6.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

7.  TRAPing a new gene for autoimmunity.

Authors:  Timothy W Behrens; Robert R Graham
Journal:  Nat Genet       Date:  2011-02       Impact factor: 38.330

Review 8.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 9.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

Review 10.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.